Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Opioid Settlement topic
No spam. Unsubscribe anytime.
Navajo County approves participation in multistate generic-opioid settlement after executive session
Summary
Following executive session for legal advice, the Board unanimously approved participation in a multistate settlement with multiple generic opioid manufacturers and authorized counsel to execute participation agreements per terms discussed in closed session.
After convening in executive session for legal advice, the Navajo County Board of Supervisors voted on Sept. 9, 2025 to approve participation in a settlement with multiple generic opioid manufacturers in the multistate litigation pending in Ohio.
Mister Moore (county legal counsel) summarized that the generic manufacturers reached a proposed settlement and asked the board for approval. The detailed payout and settlement terms were discussed in executive session and were not disclosed during the public portion of the meeting. A supervisor moved to approve the settlements "according to the payout or the settlement agreement amount that we've discussed in executive session;" the motion was seconded and the board adopted the motion unanimously.
The board's public record identifies the generic manufacturers discussed during the executive-session notice, including (as listed in the meeting agenda) Alvogen Inc., Amneal Pharmaceuticals, Inc., Apotex Corp., Aurobindo Pharma USA Inc., among others. The motion authorized county counsel to execute the participation agreement with the listed manufacturers per the settlement terms discussed in executive session. The transcript does not include the settlement payout amounts or the precise distribution schedule for county receipts; those details are recorded in executive-session materials or the settlement documentation.
